Hypertension
Conference Coverage
High-tech pills help increase medication adherence
Key clinical point: Feedback from a system of digital-enabled pills enhanced medication adherence. Major finding: Patients using Proteus had 84%...
News
Obesity paradox extends to TAVR but not SAVR
PARIS – Thirty-day and 1-year mortality rates were lowest in the top BMI quartile of TAVR patients and highest in the bottom BMI quartile.
Video
VIDEO: HOPE-3 bolsters primary prevention in intermediate-risk patients
Conference Coverage
VIDEO: HOPE-3 trial supports broader role for statins in primary prevention
HOPE-3 “suggests you can essentially double the benefit of lowering blood pressure in hypertensives if you also lower cholesterol simultaneously...
Conference Coverage
VIDEO: HOPE-3 trial expands scope of primary cardiovascular prevention
Hypertensive patients benefit from moderate-dose statin regardless of LDL level.
Conference Coverage
Heart attack patients getting younger, fatter, and less healthy
Key clinical point: Despite advances in understanding heart disease prevention, patients with heart attack are younger and less healthy than they...
News
CV health may prevent cognitive decline
Key clinical point: The closer adults come to meeting “ideal” American Heart Association targets for seven factors related to cardiovascular...
News
No LIGHT shed on CV safety of naltrexone-bupropion
Key clinical point: The cardiovascular risks of the weight-loss combination drug naltrexone-bupropion are still uncertain. Major finding: The...
News
Pediatric BMI increases linked to rises in blood pressure, hypertension risk
Children’s and adolescents’ risk of blood pressure increases and hypertension rose as their body mass index increased, even over a short period of...
News
Primary care endures in heart failure management
News
Chlorthalidone controls blood pressure longer than HCTZ
While standard hydrochlorothiazide has been the more widely prescribed diuretic treatment for essential hypertension for decades, control is...